This New Whey Protein Hydrolysate from Arla is Easy to Digest
Michael Hemsworth — November 11, 2024 — Lifestyle
References: arlafoodsingredients & foodbev
Arla Foods Ingredients has announced a new whey protein hydrolysate that addresses a number of key challenges related to peptide-based medical nutrition. The ingredient, called Lacprodan DI-3092, is reported to deliver 10-grams of protein per 100ml that's positioned as much higher than the typical six or seven-grams that's found in similar products. The solution is reported to have a mild taste, low viscosity and an easily digestible profile for make it suitable for patients with impaired gastrointestinal functions or issues related to nutrient absorption.
Head of Sales Development for Specialised Nutrition at Arla Foods Ingredients Mads Dyrvig spoke on the whey protein hydrolysate saying, "Whey protein hydrolysates are essential for peptide-based medical nutrition but there are three key challenges in the category. The first is to improve taste and texture, which is important to ensure patient compliance. The second is to go higher in protein and the third is to do that using a high-quality protein source. Lacprodan DI-3092 – our best-tasting whey protein hydrolysate yet – overcomes all three challenges.”
Head of Sales Development for Specialised Nutrition at Arla Foods Ingredients Mads Dyrvig spoke on the whey protein hydrolysate saying, "Whey protein hydrolysates are essential for peptide-based medical nutrition but there are three key challenges in the category. The first is to improve taste and texture, which is important to ensure patient compliance. The second is to go higher in protein and the third is to do that using a high-quality protein source. Lacprodan DI-3092 – our best-tasting whey protein hydrolysate yet – overcomes all three challenges.”
Trend Themes
1. Enhanced Nutritional Solutions - The introduction of Lacprodan DI-3092 reflects a growing trend in enhancing the nutritional profile of peptide-based medical nutrition products to address specific health issues.
2. Patient-centric Formulations - Arla's focus on improving taste and texture in whey protein hydrolysates highlights an industry trend towards developing patient-centric medical nutrition solutions that encourage compliance.
3. Digestibility Focus - Innovations like easily digestible protein hydrolysates underscore the trend of prioritizing digestive health and nutrient absorption in medical nutrition.
Industry Implications
1. Medical Nutrition - Lacprodan DI-3092 represents significant progress in the Medical Nutrition industry by addressing key patient needs such as improved taste, texture, and protein content.
2. Supplement Manufacturing - The introduction of high-quality, digestible whey protein hydrolysates can transform the Supplement Manufacturing industry, setting new standards for product efficacy and patient satisfaction.
3. Gastrointestinal Health - This new ingredient spotlight's importance in the Gastrointestinal Health industry, paving the way for products that cater specifically to individuals with impaired digestive functions.
4.4
Score
Popularity
Activity
Freshness
